BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12202623)

  • 1. Ligation of a primer at a mutation: a method to detect low level mutations in DNA.
    Kaur M; Zhang Y; Liu WH; Tetradis S; Price BD; Makrigiorgos GM
    Mutagenesis; 2002 Sep; 17(5):365-74. PubMed ID: 12202623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An amplification and ligation-based method to scan for unknown mutations in DNA.
    Zhang Y; Kaur M; Price BD; Tetradis S; Makrigiorgos GM
    Hum Mutat; 2002 Aug; 20(2):139-47. PubMed ID: 12124995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hotspot mutations and polymorphisms using an enhanced PCR-RFLP approach.
    Liu WH; Kaur M; Makrigiorgos GM
    Hum Mutat; 2003 May; 21(5):535-41. PubMed ID: 12673796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of primer engineered multiplex polymerase chain reaction-restriction fragment length polymorphism for detection of factor V Leiden and prothrombin G20210A.
    Huber S; McMaster KJ; Voelkerding KV
    J Mol Diagn; 2000 Aug; 2(3):153-7. PubMed ID: 11229520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the amplification refractory mutation allele-specific polymerase chain reaction system for sensitive and specific detection of p53 mutations in DNA.
    Low EO; Jones AM; Gibbins JR; Walker DM
    J Pathol; 2000 Mar; 190(4):512-5. PubMed ID: 10700003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent detection of ras and p53 mutations in brush cytology samples from lung cancer patients by a restriction fragment length polymorphism-based "enriched PCR" technique.
    Behn M; Qun S; Pankow W; Havemann K; Schuermann M
    Clin Cancer Res; 1998 Feb; 4(2):361-71. PubMed ID: 9516924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of minority point mutations by modified PCR technique: a new approach for a sensitive diagnosis of tumor-progression markers.
    Haliassos A; Chomel JC; Grandjouan S; Kruh J; Kaplan JC; Kitzis A
    Nucleic Acids Res; 1989 Oct; 17(20):8093-9. PubMed ID: 2573037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotypic mutation analysis by RFLP/PCR.
    Pourzand C; Cerutti P
    Mutat Res; 1993 Jul; 288(1):113-21. PubMed ID: 7686255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations of the p53 tumor suppressor gene in children with osteosarcoma.
    McIntyre JF; Smith-Sorensen B; Friend SH; Kassell J; Borresen AL; Yan YX; Russo C; Sato J; Barbier N; Miser J
    J Clin Oncol; 1994 May; 12(5):925-30. PubMed ID: 8164043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue.
    Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F
    Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enriched SSCP: a highly sensitive method for the detection of unknown mutations. Application to the molecular diagnosis of lung cancer in sputum samples.
    Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bertacca G; Merlo G; Bevilacqua G
    Diagn Mol Pathol; 1997 Aug; 6(4):185-91. PubMed ID: 9360839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of alterations in p53, K-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black.
    Swafford DS; Nikula KJ; Mitchell CE; Belinsky SA
    Carcinogenesis; 1995 May; 16(5):1215-21. PubMed ID: 7539340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Needle-in-a-haystack detection and identification of base substitution mutations in human tissues.
    Wilson VL; Wei Q; Wade KR; Chisa M; Bailey D; Kanstrup CM; Yin X; Jackson CM; Thompson B; Lee WR
    Mutat Res; 1999 Aug; 406(2-4):79-100. PubMed ID: 10479725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
    Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
    Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly selective isolation of unknown mutations in diverse DNA fragments: toward new multiplex screening in cancer.
    Chakrabarti S; Price BD; Tetradis S; Fox EA; Zhang Y; Maulik G; Makrigiorgos GM
    Cancer Res; 2000 Jul; 60(14):3732-7. PubMed ID: 10919642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of K-ras and p53 mutations by "mutant-enriched" PCR-RFLP.
    Schuermann M
    Methods Mol Med; 2003; 75():325-33. PubMed ID: 12407750
    [No Abstract]   [Full Text] [Related]  

  • 17. A highly sensitive detection method for somatic mutations in p53 gene.
    Sato T; Sato A; Ishihara H; Konishi K
    Rinsho Byori; 2003 Feb; 51(2):98-106. PubMed ID: 12690626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hOGG1 Ser326Cys polymorphism and G:C-to-T:A mutations: no evidence for a role in tobacco-related non small cell lung cancer.
    Hu YC; Ahrendt SA
    Int J Cancer; 2005 Apr; 114(3):387-93. PubMed ID: 15551330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis using the restriction site mutation (RSM) assay.
    Jenkins GJ; Chaleshtori MH; Song H; Parry JM
    Mutat Res; 1998 Sep; 405(2):209-20. PubMed ID: 9748583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allele-specific PCR analysis of p53 codon 249 AGT transversion in liver tissues from patients with viral hepatitis.
    Kirby GM; Batist G; Fotouhi-Ardakani N; Nakazawa H; Yamasaki H; Kew M; Cameron RG; Alaoui-Jamali MA
    Int J Cancer; 1996 Sep; 68(1):21-5. PubMed ID: 8895534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.